FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology, ophthalmic surgery, physiotherapy. In case of localization of inflammatory focus in orbit without involvement into the process of paraorbital areas hospitalisation of patient into ophthalmology department of hospital is carried out. Orbitotomy in one or more quadrants is performed. Traditional intensive therapy is carried out. In case of intraorbital complications second stage of treatment is carried out. 1% solution of nicotinic acid is introduced intravenously in dose 2 ml on the first day, with daily 0.5-1.0 ml increase on the following days until maximal therapeutic efficiency is achieved, after that, successively dose is daily reduced by 0.5-1.0 ml to initial dose. Additionally after each injection of nicotinic acid, intravenous drip infusion of 2% pentoxifylline 5 ml on physiological solution in dose 100-200 ml is carried out during 7-15 days. Parabulbarly dexason 0.4% in dose 0.5 ml is introduced. Intramuscularly introduced are lidase in dose 64 U, actovegin in dose 2 ml and proserin 0.05% in dose 1 ml daily during 10 days. Electrophoresis with 0.05% proserin is carried out alternately with 0.5% hydrocortosone emulsion endonasally in case of optic nerve neuritis and bath method - in case of affection of eye-moving muscles with course of 10-15 procedures. If inflammatory process spreads into orbit from anatomically adjacent regions hospitalisation into otolaryngology department or into department of maxillofacial surgery, or neurosurgery or septic department of hospital is carried out. Sanitation of primary focuses of purulent infection is carried out. Traditional intensive therapy, which includes antibacterial, detoxication, desensibilising, immunologic and vitamin therapy, is performed. In case of intraorbital complications second stage of treatment is carried out in ophthalmology department of hospital.
EFFECT: method ensures obtaining early functional and cosmetic effect, prevents spread of inflammatory process into skull cavity.
5 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OPTICAL NEURITIS TREATMENT | 2009 |
|
RU2414900C1 |
METHOD FOR PREDICTING THE TYPE OF TREATMENT OF RHINOSINUSOGENIC COMPLICATIONS OF THE ORBIT AND EYELIDS IN INFLAMMATORY DISEASES OF THE PARANASAL SINUSES IN CHILDREN | 2021 |
|
RU2761716C1 |
METHOD OF SURGICAL TREATMENT OF ORBIT PHLEGMON OF ODONTOGENIC ORIGIN | 2007 |
|
RU2370247C2 |
METHOD OF SURGICAL TREATMENT OF SUBPERIOSTEAL ABSCESS OF INTERNAL WALL OF ORBIT | 2011 |
|
RU2458660C1 |
METHOD FOR PREDICTING ACUTE FLOW OF CHLAMYDIAL CONJUNCTIVITIS | 2004 |
|
RU2281503C1 |
METHOD OF COMBINED CONSERVATIVE TREATMENT OF ACTIVE ENDOCRINE OPHTHALMOPATHY | 2022 |
|
RU2806503C1 |
METHOD FOR THE TREATMENT OF OPTIC NEUROPATHY IN PATIENTS WITH EDEMATOUS EXOPHTHALMOS | 2020 |
|
RU2742188C1 |
METHOD OF DEEP LATERAL BONE DECOMPRESSION OF THE ORBIT | 2023 |
|
RU2804694C1 |
METHOD FOR PREDICTION OF PURULENT-SEPTIC RHINOSINUSOGENIC COMPLICATIONS OF ORBIT AND EYELIDS IN INFLAMMATORY PARANASAL SINUS INFECTIONS IN CHILDREN | 2020 |
|
RU2732527C1 |
METHOD OF TREATING TOXIC OPTIC NEUROPATHY, INDUCED BY LONG INTAKE OF CODEINE-CONTAINING MEDICATIONS | 2010 |
|
RU2424796C1 |
Authors
Dates
2011-12-10—Published
2010-05-28—Filed